Anika Therapeutics Stock Options Expiring on 21st of March
| ANIK Stock | USD 16.22 0.28 1.70% |
Anika Therapeutics' latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.2 with a put-to-call open interest ratio of 0.08 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on March 21st 2025.
Open Interest Against March 21st 2025 Option Contracts
2025-03-21
The chart above shows Anika Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Anika Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Anika Therapeutics' option, there is no secondary market available for investors to trade.
Anika Therapeutics In The Money Call Balance
When Anika Therapeutics' strike price is surpassing the current stock price, the option contract against Anika Therapeutics stock is said to be in the money. When it comes to buying Anika Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Anika Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Anika Current Options Market Mood
Anika Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Anika Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Anika Therapeutics' options investors are not very successful. Anika Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Anika contract
Base on the Rule 16, the options market is currently suggesting that Anika Therapeutics will have an average daily up or down price movement of about 0.075% per day over the life of the 2025-03-21 option contract. With Anika Therapeutics trading at USD 16.22, that is roughly USD 0.0122. If you think that the market is fully incorporating Anika Therapeutics' daily price movement you should consider buying Anika Therapeutics options at the current volatility level of 1.2%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Anika |
Anika Therapeutics Option Chain
When Anika Therapeutics' strike price is surpassing the current stock price, the option contract against Anika Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Anika Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Anika. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Anika. It also shows strike prices and maturity days for a Anika Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ANIK250321C00010000 | 0 | 10.0 | 4.4 - 8.5 | 4.4 | In |
Call | ANIK250321C00012500 | 5 | 12.5 | 2.05 - 6.4 | 4.9 | In |
Call | ANIK250321C00015000 | 0 | 15.0 | 0.55 - 3.8 | 0.55 | In |
Call | ANIK250321C00017500 | 1 | 17.5 | 0.0 - 3.0 | 1.7 | Out |
Call | ANIK250321C00020000 | 7 | 20.0 | 0.0 - 1.9 | 0.26 | Out |
Call | ANIK250321C00022500 | 3 | 22.5 | 0.0 - 0.5 | 0.2 | Out |
Call | ANIK250321C00025000 | 2 | 25.0 | 0.0 - 2.0 | 2.95 | Out |
Call | ANIK250321C00030000 | 41 | 30.0 | 0.0 - 0.5 | 0.2 | Out |
Call | ANIK250321C00035000 | 1 | 35.0 | 0.0 - 4.8 | 1.1 | Out |
Call | ANIK250321C00040000 | 0 | 40.0 | 0.0 - 2.0 | 2.0 | |
Put | ANIK250321P00010000 | 0 | 10.0 | 0.0 - 2.0 | 2.0 | |
Put | ANIK250321P00012500 | 0 | 12.5 | 0.0 - 2.75 | 2.75 | |
Put | ANIK250321P00015000 | 0 | 15.0 | 0.0 - 2.55 | 2.55 | |
Put | ANIK250321P00017500 | 3 | 17.5 | 0.55 - 3.9 | 1.97 | In |
Put | ANIK250321P00020000 | 1 | 20.0 | 2.3 - 5.7 | 3.2 | In |
Put | ANIK250321P00022500 | 1 | 22.5 | 4.9 - 7.7 | 1.55 | In |
Put | ANIK250321P00025000 | 0 | 25.0 | 6.7 - 10.9 | 6.7 | In |
Put | ANIK250321P00030000 | 0 | 30.0 | 11.8 - 16.0 | 11.8 | In |
Put | ANIK250321P00035000 | 0 | 35.0 | 16.7 - 20.2 | 16.7 | In |
Put | ANIK250321P00040000 | 0 | 40.0 | 22.0 - 25.1 | 22.0 | In |
Anika Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Anika Total Stockholder Equity
Total Stockholder Equity |
|
Anika Therapeutics Corporate Management
| Ian McLeod | VP Officer | Profile | |
| James Chase | Senior Marketing | Profile | |
| Bart Bracy | VP Americas | Profile | |
| Lisa Funiciello | Vice Resources | Profile | |
| Mark Namaroff | Executive Communications | Profile | |
| Michael CPA | Executive Officer | Profile | |
| Charles III | VP Counsel | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (6.64) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.